. 2019 Aug 30;98(35):e17007. doi: 10.1097/MD.0000000000017007
Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc.
This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
Table 3.
Transarterial therapy and adverse events in CKD and non-CKD groups.
